RESUMO
BACKGROUND: Currently fungal infections have been increasing in clinical aspect. Among them Candida albicans is considered as the most pathogenic. National Committee for Clinical Laboratory Standards(NCCLS) recommends broth macrodilution method for antifungal susceptibility test, but it is difficult to perform. E test is a relatively easy method to perform for the susceptibility testing. So in this study, antifungal susceptibility procedures were compared to determine MIC for fluconazole against 130 Candida strains isolated from clinical specimens. METHOD: The tests including were microdilution method, E test and disk diffusion method. The latter two tests were performed in casitone agar and the former test performed in RPMI 1640 media(Sigma Chemical co. St. Louis, USA). MIC was determined after 24 hrs of incubation. We used Candida albicans ATCC 90018 and Candida parapsilosis ATCC 90028 as controls. A total of 130 strains(93 C. albicans, 29 C. tropicalis, 5 C. parapsilosis and 3 C. glabrata) were tested. RESULTS: The MIC50 and MIC90 of broth microdilution test for C. albicans was > OR =64 microgram/mL equivalently. Agreement of > OR = +/-2 dilution between broth microdilution test and E test was 54 %, and the concordance rate was 55%. The concordance rate between E test and disk diffusion was 90%. CONCLUSIONS: From this study, we conclude that E test can be used as a alternative and convenient method to macrodilution method to determine MIC of fluconazole. But it is necessary for attention to microcolonies surrounding the E test strip. Disk diffusion method is rapid and also can be used as an alternative and convenient method.
Assuntos
Ágar , Candida albicans , Candida , Difusão , FluconazolRESUMO
BACKGROUND: Hepatitis B virus(HBV) DNA integration is one of the cause of hepatocellular carcinoma (HCC). Epidemiologic evidences indicate that HBV infection is associated with the high risk of development of HCC. We wanted to evaluate the HBV DNA integration in hepatocellular carcinoma. So we detected HBV DNA by PCR in aseptically obtained 37 HCC tissues. METHODS: A total 37 surgical specimens from HCC patients were evaluated. Patient's serologic findings were analyzed retrospectively. Serologic markers were tested by radioimmunoassay. Genomic DNA was extracted from HCC paraffin blocks by microwave oven method. PGR was done. RESULTS: The sensitivity of HBV DNA PCR was 100 fg. Among 37 Patients tested, 30 cases of HCC patients had HBV DNA in their liver tissue. Among 25 HBs Ag positive patients, 23 had PCR positive results. All of the anti-HBc positive patients had HBV DNA. CONCLUSIONS: These findings are highly suggestive of HBV infection in the development of hepatocellular carcinoma. Detection of HBV DNA in patients with hepatocellular carcinoma is highly suggestive of HBV infection in the development of hepatocellular carcinoma.